A NAFZIGER

403 total citations
10 papers, 341 citations indexed

About

A NAFZIGER is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, A NAFZIGER has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in A NAFZIGER's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). A NAFZIGER is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). A NAFZIGER collaborates with scholars based in United States, Russia and Singapore. A NAFZIGER's co-authors include Joseph Bertino, Ellen Chung, Richie Soong, Serene M. L. Lee, Lai Tham, Boon Cher Goh, Lu Wang, Jia Guo, L. Andrew Lee and Daniel S. Streetman and has published in prestigious journals such as Clinical Pharmacology & Therapeutics.

In The Last Decade

A NAFZIGER

9 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A NAFZIGER United States 5 264 93 77 59 53 10 341
George Davis United States 4 213 0.8× 79 0.8× 55 0.7× 37 0.6× 54 1.0× 7 325
MT Lee Taiwan 4 319 1.2× 52 0.6× 57 0.7× 95 1.6× 34 0.6× 6 461
Dorothee Frank Germany 7 254 1.0× 132 1.4× 48 0.6× 89 1.5× 31 0.6× 7 428
Mia Sandberg Sweden 7 240 0.9× 113 1.2× 64 0.8× 40 0.7× 59 1.1× 8 343
Benjamin D. Horne United States 5 314 1.2× 34 0.4× 117 1.5× 38 0.6× 71 1.3× 5 398
Susan K. Gatchel United States 8 360 1.4× 41 0.4× 154 2.0× 49 0.8× 73 1.4× 10 539
Jason Hubbard United States 2 333 1.3× 44 0.5× 143 1.9× 30 0.5× 78 1.5× 3 392
M.E.G. Naranjo Spain 10 305 1.2× 114 1.2× 34 0.4× 76 1.3× 24 0.5× 12 425
Teppei Shimizu Japan 5 251 1.0× 82 0.9× 80 1.0× 28 0.5× 76 1.4× 6 358
Kristen K. Reynolds United States 10 277 1.0× 38 0.4× 97 1.3× 52 0.9× 54 1.0× 15 363

Countries citing papers authored by A NAFZIGER

Since Specialization
Citations

This map shows the geographic impact of A NAFZIGER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A NAFZIGER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A NAFZIGER more than expected).

Fields of papers citing papers by A NAFZIGER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A NAFZIGER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A NAFZIGER. The network helps show where A NAFZIGER may publish in the future.

Co-authorship network of co-authors of A NAFZIGER

This figure shows the co-authorship network connecting the top 25 collaborators of A NAFZIGER. A scholar is included among the top collaborators of A NAFZIGER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A NAFZIGER. A NAFZIGER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chung, Ellen, et al.. (2006). Comparison of midazolam and simvastatin as cytochrome P450 3A probes. Clinical Pharmacology & Therapeutics. 79(4). 350–361. 96 indexed citations
2.
Bertino, Joseph, et al.. (2006). Sex differences in CYP3A activity using intravenous and oral midazolam. Clinical Pharmacology & Therapeutics. 80(5). 531–538. 53 indexed citations
3.
Tham, Lai, Boon Cher Goh, A NAFZIGER, et al.. (2006). A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9. Clinical Pharmacology & Therapeutics. 80(4). 346–355. 119 indexed citations
4.
Lee, L. Andrew, A NAFZIGER, & Joseph Bertino. (2005). Evaluation of inhibitory drug interactions during drug development: Genetic polymorphisms must be considered. Clinical Pharmacology & Therapeutics. 78(1). 1–6. 46 indexed citations
5.
Ma, Jian‐Gong, A NAFZIGER, Stephen Villano, Jennifer Victory, & Joseph Bertino. (2005). Single and multiple dose pharmacokinetics (PK) of maribavir (MB) in healthy adults. Clinical Pharmacology & Therapeutics. 77(2). P19–P19. 1 indexed citations
6.
7.
8.
Streetman, Daniel S., A NAFZIGER, J. Steven Leeder, et al.. (1999). Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping. Clinical Pharmacology & Therapeutics. 66(5). 535–541. 17 indexed citations
9.
Kashuba, Angela D. M., A NAFZIGER, G KEARNS, et al.. (1999). Dextromethorphan (DM) N-demethylation (N-D) does not accurately reflect hepatic CYP3A phenotype. Clinical Pharmacology & Therapeutics. 65(2). 170–170. 3 indexed citations
10.
Kim, Jin‐Tae, et al.. (1999). Optimal plasma sampling to predict AUC of the CYP3A probe midazolam (MID). Clinical Pharmacology & Therapeutics. 65(2). 185–185. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Davis Breakdown of academic impact, for papers by MT Lee Breakdown of academic impact, for papers by Dorothee Frank Breakdown of academic impact, for papers by Mia Sandberg Breakdown of academic impact, for papers by Benjamin D. Horne Breakdown of academic impact, for papers by Susan K. Gatchel Breakdown of academic impact, for papers by Jason Hubbard Breakdown of academic impact, for papers by M.E.G. Naranjo Breakdown of academic impact, for papers by Teppei Shimizu Breakdown of academic impact, for papers by Kristen K. Reynolds
Rankless by CCL
2026